Is Estrogen Preferable to Surgery for Postmenopausal Women with Primary Hyperparathyroidism?
- 5 June 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 314 (23), 1508-1509
- https://doi.org/10.1056/nejm198606053142309
Abstract
Most people can agree that primary hyperparathyroidism is not uncommon,1 especially among postmenopausal women,1 , 2 and that it is best treated with curative parathyroidectomy when complicated by renal stones, bone disease, calcium levels above 12 mg per deciliter, hypertension, or reduced renal function. Medical palliation3 is generally accepted for patients who are too frail for surgery or who reject it, and for those who have other diseases that will drastically shorten their lives. But what is best for uncomplicated hyperparathyroidism discovered in symptomless patients by routine blood screening? Do these patients need a cure? Do they benefit from medical palliation?The . . .Keywords
This publication has 12 references indexed in Scilit:
- Ethinyl Estradiol and Norethindrone in the Treatment of Primary Hyperparathyroidism in Postmenopausal WomenNew England Journal of Medicine, 1986
- Long-Term Estrogen Replacement Therapy Prevents Bone Loss and FracturesAnnals of Internal Medicine, 1985
- Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.Journal of Clinical Investigation, 1982
- PRIMARY HYPERPARATHYROIDISM: CHANGES IN THE PATTERN OF CLINICAL PRESENTATIONThe Lancet, 1980
- Does Mild, Asymptomatic Hyperparathyroidism Require Surgery?New England Journal of Medicine, 1980
- Primary HyperparathyroidismNew England Journal of Medicine, 1980
- Treatment of primary hyperparathyroidismThe American Journal of Medicine, 1974
- TREATMENT WITH ŒSTROGENS OF PRIMARY HYPERPARATHYROIDISM IN POST-MENOPAUSAL WOMENThe Lancet, 1972